FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology. A peripheral laser iridotomy is performed in a patient with primary closed-angle glaucoma. No less than 2 months later, corneal endothelium density and depth of anterior eye chamber are determined. If corneal endothelium density is not less than 2,436 cells/mm2, anterior chamber depth of at least 2.62 mm, patient aged no more than 65 years perform selective laser trabeculoplasty.
EFFECT: method enables preserving the corneal endothelium and preventing its decompensation after the combined treatment with excluding the adverse effect of laser radiation on the corneal endothelium.
1 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CHOOSING THE TACTICS OF SURGICAL TREATMENT OF PATIENTS WITH PRIMARY CLOSURE OF THE ANGLE OF THE ANTERIOR CHAMBER OF THE EYE | 2023 |
|
RU2797850C1 |
| METHOD OF REDUCING INTRAOCULAR PRESSURE BY PERIPHERAL LASER IRIDOTOMY | 2023 |
|
RU2817339C1 |
| METHOD FOR DETERMINING THE TACTICS OF SURGICAL MANAGEMENT OF PATIENTS WITH A LATENT STAGE OF CLOSED ANGULAR GLAUCOMA | 2020 |
|
RU2741203C1 |
| METHOD OF DEFINING INDICATIONS FOR SELECTIVE LASER TRABECULOPLASTY FOR PRIMARY WIDE-ANGLE GLAUCOMA | 2007 |
|
RU2332158C1 |
| METHOD OF THE TREATMENT OF PRIMARY ANGLE-CLOSURE GLAUCOMA WITH ORGANIC BLOCKADE OF THE ANTERIOR CHAMBER ANGLE | 2023 |
|
RU2798324C1 |
| METHOD FOR SURGICAL TREATMENT OF GLAUCOMA | 2004 |
|
RU2281073C2 |
| METHOD FOR PREVENTING PIGMENTED GLAUCOMA ACCOMPANYING SYNDROME OF PIGMENT DISPERSION | 2019 |
|
RU2731885C2 |
| METHOD FOR ENHANCING THE HYPOTENSIVE EFFECT OF SELECTIVE LASER TRABECULOPLASTY | 2022 |
|
RU2795723C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF OPTICAL NEUROPATHY IN PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2706956C1 |
| METHOD FOR SURGICAL TREATMENT OF CLOSED-ANGLE GLAUCOMA WITH ORGANIC BLOCK OF ANGLE OF ANTERIOR CHAMBER WITH PRESERVING NATIVE CRYSTALLINE LENS | 2012 |
|
RU2524197C2 |
